App-based program aims to slow kidney disease with lifestyle support

NCT ID NCT06756113

Completed Disease control Sponsor: National Cheng Kung University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a digital program called DDEP, delivered through the LINE messaging app, to help people with chronic kidney disease (CKD) and their care partners make healthy lifestyle changes. Over six months, 208 participants either received the DDEP plus usual care or usual care alone. The goal was to see if the program could protect kidney function and support healthier daily habits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Digital Dyadic Empowerment Program (DDEP) via LINE app
What this could lead to: If successful, this program could offer a simple, scalable way to help CKD patients and their care partners adopt healthier habits and slow kidney decline.
What could go wrong: This is a completed trial with 208 participants, but it's a behavioral intervention—results may vary by culture or tech access, and it doesn't test a drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES

Contacts and locations

Locations

National Cheng Kung University

Tainan, 70101, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.